(E)-N-[4-(3-chloro-4-fluoroanilino)thieno[3,2-d]pyrimidin-6-yl]-3-phenylprop-2-enamide
C21H14ClFN4OS — CID 155512812
Data last refreshed: (MolForge compound catalog, from PubChem)
About (E)-N-[4-(3-chloro-4-fluoroanilino)thieno[3,2-d]pyrimidin-6-yl]-3-phenylprop-2-enamide
(E)-N-[4-(3-chloro-4-fluoroanilino)thieno[3,2-d]pyrimidin-6-yl]-3-phenylprop-2-enamide (PubChem CID 155512812) has the molecular formula C21H14ClFN4OS and a molecular weight of 424.89 g/mol. Its IUPAC name is (E)-N-[4-(3-chloro-4-fluoroanilino)thieno[3,2-d]pyrimidin-6-yl]-3-phenylprop-2-enamide.
Molecular Properties
| Compound Name | (E)-N-[4-(3-chloro-4-fluoroanilino)thieno[3,2-d]pyrimidin-6-yl]-3-phenylprop-2-enamide |
|---|---|
| PubChem CID | 155512812 |
| Molecular Formula | C21H14ClFN4OS |
| Molecular Weight | 424.89 g/mol |
| Exact Mass | 424.06 |
| IUPAC Name | (E)-N-[4-(3-chloro-4-fluoroanilino)thieno[3,2-d]pyrimidin-6-yl]-3-phenylprop-2-enamide |
| SMILES | O=C(/C=C/c1ccccc1)Nc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2s1 |
| InChI | InChI=1S/C21H14ClFN4OS/c22-15-10-14(7-8-16(15)23)26-21-20-17(24-12-25-21)11-19(29-20)27-18(28)9-6-13-4-2-1-3-5-13/h1-12H,(H,27,28)(H,24,25,26)/b9-6+ |
| InChIKey | QYSPUHCWSARYAQ-RMKNXTFCSA-N |
| XLogP | 5.88 |
| TPSA | 66.91 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 424.89 |
| LogP ≤ 5 | 5.88 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155512812 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.